Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout

Fitzgerald, John; Mikuls, Ted R.; Neogi, Tuhina; Singh, Jasvinder A.; Robbins, Mark L.; Khanna, Puja P.; Turner, Amy S.; Myslinski, Rachel; Suter, Lisa G.

doi:10.1002/acr.23500

Cited by 24 publications

(18 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These measurements can then be used to evaluate standard care considering the outcome. Although electronic quality measures show promise in supporting to achieve potential goals of quality interventions, current studies suggest that significant infrastructure and analytical support at the practice level is necessary to integrate such electronic quality measurements into the existing health care systems ( 33 ). For rheumatic diseases with multiorgan manifestations and multiple disciplines, such standardized data acquisition should be carried out on an interdisciplinary platform.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Identification of Five Quality Needs for Rheumatology (Text Analysis and Literature Review)

Pallua

Schirmer

2021

Front. Med.

View full text Add to dashboard Cite

Background: While the use of the term “quality” in industry relates to the basic idea of making processes measurable and standardizing processes, medicine focuses on achieving health goals that go far beyond the mere implementation of diagnostic and therapeutic processes. However, the quality management systems used are often simple, self-created concepts that concentrate on administrative processes without considering the quality of the results, which is essential for the patient. For several rheumatic diseases, both outcome and treatment goals have been defined. This work summarizes current mainstreams of strategies with published quality efforts in rheumatology.Methods: PubMed, Cochrane Library, and Web of Science were used to search for studies, and additional manual searches were carried out. Screening and content evaluation were carried out using the PRISMA-P 2015 checklist. After duplicate search in the Endnote reference management software (version X9.1), the software Rayyan QCRI (https://rayyan.qcri.org) was applied to check for pre-defined inclusion and exclusion criteria. Abstracts and full texts were screened and rated using Voyant Tools (https://voyant-tools.org/). Key issues were identified using the collocate analysis.Results: The number of selected publications was small but specific (14 relevant correlations with coefficients >0.8). Using trend analysis, 15 publications with relative frequency of keywords >0.0125 were used for content analysis, revealing 5 quality needs. The treat to target (T2T) initiative was identified as fundamental paradigm. Outcome parameters required for T2T also allow quality assessments in routine clinical work. Quality care by multidisciplinary teams also focusing on polypharmacy and other quality aspects become essential, A global software platform to assess quality aspects is missing. Such an approach requires reporting of multiple outcome parameters according to evidence-based clinical guidelines and recommendations for the different rheumatic diseases. All health aspects defined by the WHO (physical, mental, and social health) have to be integrated into the management of rheumatic patients.Conclusion: For the future, quality projects need goals defined by T2T based initiatives in routine clinical work, secondary quality goals include multidisciplinary cooperation and reduction of polypharmacy. Quality indicators and standards in different health systems will provide new information to optimize patients' care in different health systems.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Out of these publications, 1 article on structure (31), 7 articles on process (24,(32)(33)(34)(35)(36)(37) and 2 articles on outcome quality (31, 38) were identified. For the WHO-defined health goals, 1 article on physical (39), no article on psychological and 1 article on social issues (40) were identified.…”

Section: Trend Analysismentioning

confidence: 99%

Identification of Five Quality Needs for Rheumatology (Text Analysis and Literature Review)

Pallua

Schirmer

2021

Front. Med.

View full text Add to dashboard Cite

show abstract

“…This will play a key role in the prevention of CVD and improve future treatment strategies. The need for active screening of CV risk factors in patients who had been diagnosed with gout is highly recommended both by the ACR and The European League Against Rheumatism (EULAR) [169,196,197].…”

Section: Most Relevant Recommendationsmentioning

confidence: 99%

Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk

Borghi¹,

Tykarski²,

Widecka³

et al. 2018

Cardiol J

View full text Add to dashboard Cite

show abstract

“…Значительное количество эпидемиологических исследований продемонстрировало, что гиперурикемия в высокой степени связана с риском развития ССЗ, ХБП и СД, в связи с чем необходимо повышенное внимание к мониторингу уровня МК в сыворотке у пациентов не только с ревматологической точки зрения, но также и в отношении снижения сердечнососудистого и почечного риска, включая измерения расчетной СКФ [39,188]. Необходимость активного скрининга сердечно-сосудистых факторов риска настоятельно рекомендуется и Американской коллегией ревматологов и Европейской лигой по борьбе с ревматизмом (EULAR) [129,189,190]. В табл.…”

Section: алгоритм ведения пациентов с гиперурикемиейunclassified

Consensus on patients with hyperuricemia and high cardiovascular risk treatment

et al. 2019

View full text Add to dashboard Cite

Substantial amount of epidemiologic studies showed that hyperuricemia is highly associated with cardiovascular disorders, chronic renal disease, and diabetes mellitus development risk. This fact shows necessity of increased focus on uric acid level in serum not only in relation to rheumatic disorders but also in relation to cardiovascular and renal risk. European Society of Cardiology and Russian Arterial Hypertension Society experts included tests on uric acid level serum concentration in routine tests for hypertensive patients. Important steps in increase of hyperuricemia control in clinical practice are increase of awareness as a risk factor of cardiovascular disorders, development of risk management algorithm for patients with hyperuricemia and high cardiovascular risk, and increase of treatment adherence. Decrease of uric acid level in serum achieved after treatment with urate decreasing therapy mostly with xanthine oxidase inhibitor is associated with improvement of blood pressure control and decrease of cardiovascular adverse events frequency.

show abstract

Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout

Cited by 24 publications

References 51 publications

Identification of Five Quality Needs for Rheumatology (Text Analysis and Literature Review)

Identification of Five Quality Needs for Rheumatology (Text Analysis and Literature Review)

Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk

Consensus on patients with hyperuricemia and high cardiovascular risk treatment

Contact Info

Product

Resources

About